Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2026-08-05 16:26:50 ET · period of report 2026-08-03 · accession 0001974200-26-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-05 16:26 | 2026-08-03 | MIRM | Howe Jolanda | SVP, Gbl Ctrl | S - Sale | $105.29 | -1,840 | 1,274 | -59% | -$193.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-03 | S | D | 1,840 | $105.29 | 1,274 | D | — | — | (F1) Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 18, 2026. |